Champions Oncology Inc. (CSBR) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Champions Oncology Inc.

    NASDAQ: CSBR · Real-Time Price · USD
    6.45
    0.06 (0.94%)
    At close: Oct 03, 2025, 3:59 PM
    6.39
    -0.93%
    After-hours: Oct 03, 2025, 04:10 PM EDT

    Champions Oncology Income Statement

    Financials in USD. Fiscal year is May - April.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Apr 30, 2025 Apr 30, 2024 Apr 30, 2023 Apr 30, 2022 Apr 30, 2021
    Revenue
    		 56.94M 50.16M 53.87M 49.11M 41.04M
    Cost of Revenue
    		 28.39M 29.4M 29.53M 23.63M 21.47M
    Gross Profit
    		 28.55M 20.75M 24.34M 25.48M 19.57M
    Operating Income
    		 4.55M -7.36M -4.45M 607K 338K
    Interest Income
    		 87K n/a n/a n/a n/a
    Pretax Income
    		 4.63M -7.31M -5.27M 583K 409K
    Net Income
    		 4.7M -7.28M -5.33M 548K 362K
    Selling & General & Admin
    		 16.88M 18.13M 17.24M 15.5M 12.03M
    Research & Development
    		 6.83M 9.54M 11.54M 9.37M 7.2M
    Other Expenses
    		 293K 435K -11K -24K 71K
    Operating Expenses
    		 24M 28.11M 28.79M 24.87M 19.23M
    Interest Expense
    		 27K n/a n/a 24K n/a
    Selling & Marketing Expenses
    		 7.54M 7.06M 7M 6.38M 5.52M
    Cost & Expenses
    		 52.39M 57.51M 58.32M 48.5M 40.7M
    Income Tax Expense
    		 -75K -32K 68K 35K 75K
    Shares Outstanding (Basic)
    		 13.66M 13.55M 13.54M 13.2M 13.14M
    Shares Outstanding (Diluted)
    		 14.27M 13.55M 13.54M 14.16M 14.57M
    EPS (Basic)
    		 0.34 -0.54 -0.39 0.04 0.03
    EPS (Diluted)
    		 0.33 -0.54 -0.39 0.04 0.02
    EBITDA
    		 6.49M -5.05M -2.07M 2.23M 366K
    EBIT
    		 4.85M -6.92M -4.45M 583K 437K
    Depreciation & Amortization
    		 1.64M 1.87M 3.2M 2.41M 1.58M

    Add to Watchlist